rSM PROGRESS. DESTINATION PATIENTS.
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients.

There are currently no openings—please check back at a later date.

Thank you for considering Arrakis Therapeutics.

Back to Top